Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

api image Metamizol-Magnesium

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Metamizol Magnesium Manufacturers in India Suppliers Metamizol Magnesium Exporters Distributors Metamizol Magnesium api active pharmaceuticals ingredients Metamizol Magnesium manufacturers Side Effects bulk drugs raw material Metamizol Magnesium companies Side Effects Importers Metamizol Magnesium Metamizol Magnesium Exporters Metamizol Magnesium exporters FDA Metamizol Magnesium DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Metamizol Magnesium manufacturing pharmaceutical drugs pharmaceutical intermediates Metamizol Magnesium pharmaceutical chemicals pharmaceutical raw materials Metamizol Magnesium active pharmaceutical ingredients Metamizol Magnesium committee active pharmaceutical ingredients manufacturer Metamizol Magnesium Active Pharmaceutical Ingredients manufacturer Metamizol Magnesium exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Metamizol Magnesium, Metamizol Magnesium manufacturer India, Metamizol Magnesium product, Metamizol Magnesium products, Api preparation, Certificate of Analysis API manufacturer product, Metamizol Magnesium anti ulcer product, Certificate of Origin COA Metamizol Magnesium COS Metamizol Magnesium, pharmaceutical generic, pharmaceutical drug, medical, Metamizol Magnesium pharma healthcare, pharma patents, contract MSDS manufacturing Trader Metamizol Magnesium pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Metamizol Magnesium expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Metamizol Magnesium DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Metamizol Magnesium ingredients, api, HIV Metamizol Magnesium, tablets, capsules, syrup & protein Metamizol Magnesium powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Metamizol Magnesium gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Metamizol Magnesium WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Mesalamine img.














 










 

 

HOME >> API >> API List 2 >> Metamizol Magnesium >> Precautions

Metamizol Magnesium CAS No. 6150-97-6

PRECAUTIONS
Metamizol Magnesium CAS No. 6150-97-6

General

Patients who receive Metamizol Magnesium  should be under close surveillance and should be cautioned to report immediately any evidence of illness, particularly sore throat, skin eruptions, fever, headache, or general malaise. In such cases, white-blood-cell and differential counts should be made to determine whether agranulocytosis has developed. Particular care should be exercised with patients who are receiving additional drugs known to cause agranulocytosis.

Laboratory Tests
Because Metamizol Magnesium  may cause hypoprothrombinemia and bleeding, prothrombin time should be monitored during therapy with the drug, especially before surgical procedures

Carcinogenesis, Mutagenesis, Impairment of Fertility

In a 2 year study, rats were given methimazole at doses of 0.5, 3, and 18 mg/kg/day. These doses were 0.3, 2, and 12 times the 15 mg/day maximum human maintenance dose (when calculated on the basis of surface area). Thyroid hyperplasia, adenoma, and carcinoma developed in rats at the two higher doses.
Pregnancy Categoryused judiciously is an effective drug in hyperthyroidism complicated by pregnancy. In many pregnant women, the thyroid dysfunction diminishes as the pregnancy proceeds; consequently, a reduction in dosage may be possible. In some instances, use of Metamizol Magnesium  can be discontinued 2 or 3 weeks before delivery.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS >>
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Metamizol Magnesium

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin

Gemcitabine Hcl

Glimepiride

Granisetron Hcl

Ibandronate Sodium

Imatinib Mesylate

Irbesartan

Irinotecan Hcl

Isradipine

Lamotrigine

Lercanidipine

Letrozole

Losartan Potassium

Loteprednol Etabonate

Magnesium Valproate

Meloxicam

Memantine Hcl

Mesalazine

Metamizol Magnesium

Metaxalone

Metformin Hcl

Metoprolol Tartrate

Mifepristone

Mirtazapine

Modafinil

Mometasone Furoate

Naltrexone Hcl

Netaglinide

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.